M60.9

M60.9 identifies muscle inflammation (myositis) when the clinical documentation does not specify the type, site, or laterality of the condition.

Verified May 8, 2026 · 5 sources ↓

Status: Billable
Chapter: 13
Related CPT: 8
Region: General

Drawn from CDCICD10DataAAPCCMS

Documentation tips

What should appear in the chart to support M60.9.

Source · Editorial brief grounded in 5 cited references ↓

Record the specific muscle group or anatomic region affected (e.g., right deltoid, bilateral paraspinals) at every encounter — this unlocks a site-specific M60 subcategory and protects against payer downcoding.
Distinguish myositis subtype in the assessment: infective (M60.0x-), interstitial (M60.1x-), foreign body granuloma (M60.2x-), or other specified (M60.8x-); each has its own billable codes.
Document relevant lab or imaging findings that confirm inflammatory muscle pathology — elevated CK/ESR/CRP, MRI signal changes, or EMG results — to support medical necessity on injection or therapy claims.
If a systemic disease (RA, SLE, scleroderma, dermatomyositis) is the underlying cause, document that relationship explicitly; code the systemic condition first and exclude M60.9.
For trigger point injection claims, verify that the payer's LCD lists M60.9 as a covered diagnosis or whether a site-specific M60.8xx code is required for approval.

Related CPT procedures

Procedure codes commonly billed with M60.9. Linking the right diagnosis to the right procedure is what establishes medical necessity.

Source · CMS LCDs · AAOS specialty guidance · claims-pattern analysis

20552 $51.77

Injection(s) into one or two muscles for single or multiple trigger points at a single session.

20553 $59.79

Injection(s) into trigger points spanning three or more muscles during a single session

20610 $68.81

Aspiration and/or injection of a major joint or bursa (shoulder, hip, knee, or subacromial bursa) performed without ultrasound guidance.

97110 $29.06

Therapeutic exercise billed per 15-minute unit, targeting strength, endurance, range of motion, or flexibility with direct one-on-one patient contact.

97012 $14.36

Mechanical traction applied to one or more areas, usually the cervical or lumbar spine, as a supervised modality during therapy.

72148 $191.72

Non-contrast MRI of the lumbar spine used to evaluate disc pathology, spinal stenosis, nerve root compression, and other structural abnormalities without administration of contrast material.

73221 $205.08

MRI of any upper extremity joint — shoulder, elbow, or wrist — performed without contrast material.

73721 $204.41

MRI of a lower extremity joint (hip, knee, or ankle) performed without contrast material.

Common coding pitfalls

The recurring mistakes coders make with M60.9 and adjacent codes.

Source · Editorial brief grounded in CDC ICD-10-CM tabular guidance, AAOS coding references, and cited references ↓

Using M60.9 when laterality and site are clearly documented — the record says 'left thigh myositis' but the coder defaults to the unspecified code; correct code is M60.852.
Failing to exclude IBM: inclusion body myositis belongs to G72.41, not M60.9; using M60.9 for a confirmed IBM diagnosis will misclassify the condition.
Coding M60.9 when the myositis is a known manifestation of a systemic disease (dermatomyositis, SLE, RA); the systemic condition should drive the code selection, not M60.9.
Submitting M60.9 as the sole diagnosis on trigger point injection claims without confirming it satisfies the applicable MAC LCD — some LCDs require site-specific M60.8xx codes for medical necessity.
Confusing myositis with myopathy: muscular dystrophies and myopathies fall under G71–G72, not M60.9.

Clinical context

Source · Editorial summary grounded in 5 cited references ↓

M60.9 is the last-resort code within category M60. Use it only when the provider's documentation confirms myositis but gives no information about the anatomic site, the specific subtype (infective, interstitial, foreign body), or laterality. If any of those elements are documented, a more specific M60 subcategory is required.

The M60 category excludes inclusion body myositis (IBM), which codes to G72.41, and the entire M60–M63 range excludes inflammatory myopathies tied to systemic conditions such as dermatomyositis/polymyositis (M33.-), rheumatoid arthritis (M05.32), systemic lupus erythematosus (M32.-), scleroderma (M34.-), Sjögren's syndrome (M35.03), and polyarteritis nodosa (M30.0). If the encounter involves one of those systemic diagnoses, code the underlying condition — not M60.9.

In an orthopedic setting, M60.9 appears most often on early-workup encounters before imaging or lab results narrow the diagnosis, or on referral notes from a primary care provider who used non-specific language. It should be replaced with a lateralized, site-specific code (e.g., M60.811 for right forearm, M60.041 for infective myositis of the right hand) as soon as the record supports it. Payers scrutinize unspecified codes on claims for trigger point injections (20552, 20553) and intramuscular steroid injections (20600 range) — expect prior-authorization pushback if M60.9 is the sole supporting diagnosis.

Frequently asked questions

Source · Generated from the editorial pipeline, verified against 5 cited references ↓

01When is M60.9 actually appropriate to bill?

M60.9 is appropriate only when the provider's documentation confirms a diagnosis of myositis but provides no detail about anatomic site, laterality, or subtype. It is a legitimate code for initial encounters or referral notes where workup is still pending, but it should be updated to a specific code once site and type are established.

02Can I use M60.9 for dermatomyositis or polymyositis?

No. Dermatomyositis and polymyositis are classified under M33.-, not M60. Using M60.9 for these conditions is a misclassification and may trigger a payer audit or claim denial.

03Does M60.9 support medical necessity for trigger point injections?

It depends on the MAC's LCD. Some local coverage determinations require a site-specific M60.8xx code rather than the unspecified M60.9. Review the applicable LCD before submitting; if M60.9 is not listed, query the provider for a more specific diagnosis.

04How does M60.9 differ from G72.41 (inclusion body myositis)?

Inclusion body myositis (IBM) is explicitly excluded from M60 by a Type 2 Excludes note and is classified at G72.41 as a neuromuscular disorder. A confirmed IBM diagnosis must be coded G72.41, not M60.9.

05What should I do if the provider documents 'myositis of the left shoulder'?

Drop M60.9 and assign the site-specific code. 'Myositis, other, left shoulder' maps to M60.812. If it is infective myositis of the left shoulder, use M60.012. The documentation supports specificity, so the unspecified code is not defensible.

06Is M60.9 valid for orthopedic post-operative muscle inflammation?

Post-operative muscle inflammation that is documented as a complication of a procedure requires a complication code from the appropriate chapter rather than M60.9. Query the provider to clarify whether the condition is a procedural complication or an incidental finding.

07Can M60.9 be reported with physical therapy CPT codes?

Yes, M60.9 can be paired with therapy CPT codes such as 97110, but expect scrutiny. Insurers may request documentation showing why a more specific diagnosis was not available. Updating to a site-specific code as soon as the record supports it reduces denial risk.

Sources & references

Editorial content was developed using the following public sources. Last verified May 8, 2026.

01CDC ICD-10-CM Tabular List 2026 (effective October 1, 2025)
02
icd10data.com
https://www.icd10data.com/ICD10CM/Codes/M00-M99/M60-M63/M60-/M60.9
03
aapc.com
https://www.aapc.com/codes/icd-10-codes/M60.9
04
cms.gov
https://www.cms.gov/medicare/coordination-benefits-recovery/overview/icd-code-lists
05
cms.gov
https://www.cms.gov/files/document/fy-2025-icd-10-cm-coding-guidelines.pdf

Mira Scribe

Mira's AI scribe captures the muscle group name, side, symptom onset, and any lab or imaging findings (elevated CK, MRI edema, EMG changes) documented during the encounter. That specificity drives assignment of a lateralized M60 subcategory instead of M60.9, preventing unspecified-code audit flags and payer denials on injection or therapy claims.

See how Mira captures M60.9 documentation